Cytokines released in IBD can promote further inflammation, bone resorption, and alter the metabolism of osteocytes by increasing receptor activators of the NFκB ligand/osteoprotegerin receptor (RANKL/OPG). The gene discussed is TNFSF11; the disease is inflammatory bowel disease.